Effect of moisturizers on epidermal barrier function

Clinics in Dermatology

Volumn 30, Issue 3, 2012, Pages 286-296

  Lodén, Marie ^a  

^a Eviderm Institute AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM LACTATE; BETAINE; CORTICOSTEROID; DERMATOLOGICAL AGENT; GLYCEROL; GLYCOLIC ACID; HUMECTANT; LACTIC ACID; MOISTURIZING AGENT; NICOTINAMIDE; PIMECROLIMUS; PLACEBO; PYROGLUTAMIC ACID; SKIN LIPID; SODIUM CHLORIDE; TACROLIMUS; UNCLASSIFIED DRUG; UREA;

ASTHMA; ATOPIC DERMATITIS; CHEMICAL COMPOSITION; CUTANEOUS PARAMETERS; DERMATITIS; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG TARGETING; DRY SKIN; ECZEMA; EPIDERMIS BARRIER; EXPERIMENTAL MODEL; HUMAN; HYDRATION; ICHTHYOSIS; LIPID BILAYER; LIPID COMPOSITION; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERMEABILITY BARRIER; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; SKIN BIOPSY; SKIN CARE; SKIN EXFOLIATION; SKIN FUNCTION; SKIN PH; SKIN STRUCTURE; SKIN SURFACE; SKIN WATER LOSS; SKINFOLD THICKNESS; STRATUM CORNEUM; SURFACE PROPERTY; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; EMOLLIENTS; EPIDERMIS; HUMANS; PERMEABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN ABSORPTION; SKIN DISEASES; WATER LOSS, INSENSIBLE;

EID: 84859772744     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.08.015     Document Type: Note

References (150)

1. Holden C., English J., Hoare C., et al. Advised best practice for the use of emollients in eczema and other dry skin conditions. J Dermatol Treat 2002, 13:103-106.
2. Buraczewska I., Berne B., Lindberg M., Torma H., Loden M. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007, 156:492-498.
3. Held E., Sveinsdottir S., Agner T. Effect of long-term use of moisturizers on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol (Stockh) 1999, 79:49-51.
4. Zachariae C., Held E., Johansen J.D., Menne T., Agner T. Effect of a moisturizer on skin susceptibility to NiCl2. Acta Derm Venereol 2003, 83:93-97.
5. Vilaplana J., Coll J., Trullás C., Axón A., Pelejero C. Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. Acta Derm Venereol (Stockh) 1992, 72:28-33.
6. Hoare C., Li Wan Po A., Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000, 4:1-191.
7. Elias P.M., Wood L.C., Feingold K.R. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 1999, 10:119-126.
8. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441-446.
9. Weidinger S., Illig T., Baurecht H., et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006, 118:214-219.
10. Rawlings A.V., Harding C.R. Moisturization and skin barrier function. Dermatol Ther 2004, 17(suppl 1):43-48.
11. Candi E., Schmidt R., Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005, 6:328-340.
12. Ginger R.S., Blachford S., Rowland J., Rowson M., Harding C.R. Filaggrin repeat number polymorphism is associated with a dry skin phenotype. Arch Dermatol Res 2005, 297:235-241.
13. Loden M., Buraczewska I., Halvarsson K. Facial anti-wrinkle cream: influence of product presentation on effectiveness: a randomized and controlled study. Skin Res Technol 2007, 13:189-194.
14. Lynfield Y.L., Schechter B.A. Choosing and using a vehicle. J Am Acad Dermatol 1984, 10:56-59.
15. Schlagel C.A., Sanborn E.C. The weights of topical preparations required for total and partial body inunction. J Invest Dermatol 1964, 42:253-256.
16. Ivens U.I., Steinkjer B., Serup J., Tetens V. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001, 145:264-267.
17. Rhodes L.E., Diffey B.L. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents. Br J Dermatol 1997, 136:12-17.
18. Johnson R., Nusbaum B.P., Horwitz S.N., Frost P. Transfer of topically applied tetracycline in various vehicles. Arch Dermatol 1983, 119:660-663.
19. Lodén M., Olsson H., Skare L., Axéll T. Instrumental and sensory evaluation of the frictional response of the skin following a single application of five moisturizing creams. J Soc Cosmet Chem 1992, 43:13-20.
20. Nicholls S., King C.S., Marks R. Short term effects of emollients and a bath oil on the stratum corneum. J Soc Cosmet Chem 1978, 29:617-624.
21. Garber C.A., Nightingale C.T. Characterizing cosmetic effects and skin morphology by scanning electron microscopy. J Soc Cosmet Chem 1976, 27:509-531.
22. Mignot J., Zahouani H., Rondot D., Nardin P. Morphological study of human skin relief. Bioeng Skin 1987, 3:177-196.
23. Lodén M., Lindberg M. The influence of a single application of different moisturizers on the skin capacitance. Acta Derm Venereol 1991, 71:79-82.
24. Lodén M. The increase in skin hydration after application of emollients with different amounts of lipids. Acta Derm Venereol 1992, 72:327-330.
25. Buraczewska I., Brostrom U., Loden M. Artificial reduction in transepidermal water loss improves skin barrier function. Br J Dermatol 2007, 157:82-86.
26. Wertz P.W., Downing D.T. Metabolism of topically applied fatty acid methyl esters in BALB/C mouse epidermis. J Dermatol Sci 1990, 1:33-38.
27. Moloney S.J. The in-vitro percutaneous absorption of glycerol trioleate through hairless mouse skin. J Pharm Pharmacol 1988, 40:819-821.
28. Rawlings A.V., Scott I.R., Harding C.R., Bowser P.A. Stratum corneum moisturization at the molecular level. J Invest Dermatol 1995, 103:731-740.
29. Escobar S.O., Achenbach R., Innantuono R., Torem V. Topical fish oil in psoriasis-a controlled and blind study. Clin Exp Dermatol 1992, 17:159-162.
30. Tollesson A., Frithz A. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis. Br J Dermatol 1993, 129:95.
31. Feingold K.R., Brown B.E., Lear S.R., Moser A.H., Elias P.M. Effect of essential fatty acid deficiency on cutaneous sterol synthesis. J Invest Dermatol 1986, 87:588-591.
32. Imokawa G., Akasaki S., Hattori M., Yoshizuka N. Selective recovery of deranged water-holding properties by stratum corneum lipids. J Invest Dermatol 1986, 87:758-761.
33. Man M.Q., Feingold K.R., Elias P.M. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 1993, 129:728-738.
34. Oudshoorn M.H., Rissmann R., van der Coelen D., Hennink W.E., Ponec M., Bouwstra J.A. Effect of synthetic vernix biofilms on barrier recovery of damaged mouse skin. Exp Dermatol 2009, 18:695-703.
35. Middleton J. Development of a skin cream designed to reduce dry and flaky skin. J Soc Cosmet Chem 1974, 25:519-534.
36. Sahlin A., Edlund F., Lodén M.A. A double-blind and controlled study on the influence of the vehicle on the skin susceptibility to stinging from lactic acid. Int J Cosmet Sci 2007, 29:385-390.
37. Lalor C.B., Flynn G.L., Weiner N. Formulation factors affecting release of drug from topical formulations. 1. Effect of emulsion type upon in vitro delivery of ethyl p-aminobenzoate. J Pharm Sci 1994, 83:1525-1528.
38. Wiren K., Frithiof H., Sjöqvist C., Loden M. Enhancement of bioavailability by lowering of fat content in topical formulations. Br J Dermatol 2008, 160:552-556.
39. Smith E.W., Meyer E., Haigh J.M. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability. Arzneimittelforschung 1990, 40:618-621.
40. Denda M., Koyama J., Namba R., Horii I. Stratum corneum lipid morphology and transepidermal water loss in normal skin and surfactant-induced scaly skin. Arch Dermatol Res 1994, 286:41-46.
41. Thune P. Evaluation of the hydration and the water-holding capacity in atopic skin and so-called dry skin. Acta Derm Venereol Suppl (Stockh) 1989, 144:133-135.
42. Lodén M., Olsson H., Axell T., Linde Y.W. Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin. Br J Dermatol 1992, 126:137-141.
43. Werner Y., Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985, 65:102-105.
44. Serup J., Blichmann C.W. Epidermal hydration of psoriasis plaques and the relation to scaling. Measurement of electrical conductance and transepidermal water loss. Acta Derm Venereol (Stockh) 1987, 67:357-359.
45. Motta S., Monti M., Sesana S., Mellesi L., Ghidoni R., Caputo R. Abnormality of water barrier function in psoriasis. Arch Dermatol 1994, 130:452-456.
46. Ghadially R., Reed J.T., Elias P.M. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996, 107:558-564.
47. Blank I.H. Factors which influence the water content of the stratum corneum. J Invest Dermatol 1952, 18:433-440.
48. Blank I.H. Further observations on factors which influence the water content of the stratum corneum. J Invest Dermatol 1953, 21:259-271.
49. Grove G.L., Kligman A.M. Corneocytes size as an indirect measure of epidermal proliferative activity. Stratum corneum 1983, 191-194. Springer-Verlag, New York. R. Marks, G. Plewig (Eds.).
50. Rougier A., Lotte C., Corcuff P., Maibach H.I. Relationship between skin permeability and corneocyte size according to anatomic site, age, and sex in man. J Soc Cosmet Chem 1988, 39:15-26.
51. Potts R.O., Francoeur M.L. The influence of stratum corneum morphology on water permeability. J Invest Dermatol 1991, 96:495-499.
52. Imokawa G., Akasaki S., Minematsu Y., Kawai M. Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res 1989, 281:45-51.
53. Leveque J.L., Grove G.L., de Rigal J., Corcuff P., Kligman A.M. Biophysical characterization of dry facial skin. J Soc Cosmet Chem 1987, 82:171-177.
54. Wehr R., Krochmal L., Raqsdale F.Bagatell.W. A controlled two-center study of lactate 12% lotion and a petrolatum-based creme in patients with xerosis. Cutis 1986, 37:205-209.
55. Rogers R.S., Callen J., Wehr R., Krochmal L. Comparative efficacy of 12% ammonium lactate lotion and 5% lactic acid lotion in the treatment of moderate to severe xerosis. J Am Acad Dermatol 1989, 21:714-716.
56. Siskin S.B., Quinlan P.J., Finkelstein M.S., Marlucci M., Maglietta T.G., Gibson J.R. The effect of ammonium lactate 12% lotion versus no therapy in the treatment of dry skin of the heels. Int J Dermatol 1983, 32:905-907.
57. Dahl M.V., Dahl A.C. 12% lactate lotion for the treatment of xerosis. Arch Dermatol 1983, 119:27-30.
58. Wehr R.F., Kantor I., Jones E.L., McPhee M.E. A controlled comparative efficacy study of 5% ammonium lactate lotion versus an emollient control lotion in the treatment of moderate xerosis. J Am Acad Dermatol 1991, 25:849-851.
59. Middleton J.D., Roberts M.E. Effect of a skin cream containing the sodium salt of pyrrolidone carboxylic acid on dry and flaky skin. J Soc Cosmet Chem 1978, 29:201-205.
60. Schölermann A., Banké-Bochita J., Bohnsack K., Rippke F., Herrmann W.M. Efficacy and safety of Eucerin 10% urea lotion in the treatment of symptoms of aged skin. J Dermatolog Treat 1998, 9:175-179.
61. Frithz A. Investigation of Cortesal, a hydrocortisone cream and its water-retaining cream base in the treatment of xerotic skin and dry eczemas. Curr Ther Res 1983, 33:930-935.
62. Grice K., Sattar H., Baker H. Urea and retinoic acid in ichthyosis and their effect on transepidermal water loss and water holding capacity of stratum corneum. Acta Derm Venereol (Stockh) 1973, 54:114-118.
63. Kuster W., Bohnsack K., Rippke F., Upmeyer H.J., Groll S., Traupe H. Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 1998, 196:217-222.
64. Serup J.A. double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme. Acta Derm Venereol Suppl 1992, 177:34-43.
65. Batt M.D., Davis W.B., Fairhurst E., Gerreard W.A., Ridge B.D. Changes in the physical properties of the stratum corneum following treatment with glycerol. J Soc Cosmet Chem 1988, 39:367-381.
66. Swanbeck G. A new treatment of ichthyosis and other hyperkeratotic conditions. Acta Derm Venereol (Stockh) 1968, 48:123-127.
67. Tagami H. Electrical measurement of the water content of the skin surface. Functional analysis of the hygroskopic property and water-holding capacity of the stratum corneum in vivo and technique for assessing moisturizing efficacy. Cosmet Toiletries 1982, 97:39-47.
68. Pope F.M., Rees J.K., Wells R.S., Lewis K.G.S. Out-patient treatment of ichthyosis: a double-blind trial of of ointments. Br J Dermatol 1972, 86:291-296.
69. Alderson S.G., Barratt M.G., Black J.G. Effect of 2-hydroxyacids on guinea-pig footpad stratum corneum: mechanical properties and binding studies. Int J Cosmet Sci 1984, 6:91.
70. Takahashi M., Machida Y., Tsuda Y. The influence of hydroxy acids on the rheological properties of stratum corneum. J Soc Cosmet Chem 1985, 36:177-187.
71. Hall K.J., Hill J.C. The skin plasticisation effect of 2-hydroxyoctanoic acid. 1: the use of potentiators. J Soc Cosmet Chem 1986, 37:397-407.
72. Jokura Y., Ishikawa S., Tokuda H., Imokawa G. Molecular analysis of elastic properties of the stratum corneum by solid-state 13C-nuclear magnetic resonance spectroscopy. J Invest Dermatol 1995, 104:806-812.
73. Horii I., Nakayama Y., Obata M., Tagami H. Stratum corneum hydration and amino acid content in xerotic skin. Br J Dermatol 1989, 121:587-592.
74. Denda M., Hori J., Koyama J., et al. Stratum corneum sphingolipids and free amino acids in experimentally-induced scaly skin. Arch Dermatol Res 1992, 284:363-367.
75. Van Scott E.J., Yu R.J. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 1984, 11:867-879.
76. Smith W.P. Comparative effectiveness of alfa-hydroxy acids on skin properties. Int J Cosmet Sci 1996, 18:75-83.
77. Thueson D.O., Chan E.K., Oechsli L.M., Hahn G.S. The roles of pH and concentration in lactic acid-induced stimulation of epidermal turnover. Dermatol Surg 1998, 24:641-645.
78. Yu R.J., Van Scott E.J. Alpha-hydroxy acids: science and therapeutic use. Cosmet Dermatol 1994, (Suppl):1-6.
79. Van Scott E.J., Yu R.J. Control of keratinization with alpha-hydroxy acids and related compounds. I. Topical treatment of ichthyotic disorders. Arch Dermatol 1974, 110:586-590.
80. Blair C. The action of a urea-lactic acid ointment in ichthyosis. With particular reference to the thickness of the horny layer. Br J Dermatol 1976, 94:145-153.
81. Norlén L., Emilson A., Forslind B. Stratum corneum swelling. Biophysical and computer assisted quantitative assessments. Arch Dermatol Res 1997, 289:506-513.
82. Caussin J., Groenink H.W., de Graaff A.M., et al. Lipophilic and hydrophilic moisturizers show different actions on human skin as revealed by cryo scanning electron microscopy. Exp Dermatol 2007, 16:891-898.
83. Fluhr J., Bornkessel A., Berardesca E. Glycerol-just a moisturizer? Biological and biophysical effects. Dry skin and moisturizers. Chemistry and function 2005, 227-243. Taylor & Francis Group, Boca Raton. 2nd ed. M. Lodén, H.I. Maibach (Eds.).
84. Rawlings A.V., Harding C., Watkinson A., Banks J., Ackerman C., Sabin R. The effect of glycerol and humidity on desmosome degradation in stratum corneum. Arch Dermatol Res 1995, 287:457-464.
85. Froebe C.L., Simion F.A., Ohlmeyer H., et al. Prevention of stratum corneum lipid phase transitions in vitro by glycerol -An alternative mechanism for skin moisturization. J Soc Cosmet Chem 1990, 41:51-65.
86. Mattai J., Froebe C.L., Rhein L.D., et al. Prevention of model stratum corneum lipid phase transitions in vitro by cosmetic additives-differential scanning calometry, optical microscopy, and water evaporation studies. J Soc Cosmet Chem 1993, 44:89-100.
87. Costa-Balogh F.O., Wennerstrom H., Wadso L., Sparr E. How small polar molecules protect membrane systems against osmotic stress: the urea-water-phospholipid system. J Phys Chem B 2006, 110:23845-23852.
88. Batt M.D., Fairhurst E. Hydration of the stratum corneum. Int J Cosmet Sci 1986, 8:253-264.
89. Wellner K., Wohlrab W. Quantitative evaluation of urea in stratum corneum of human skin. Arch Dermatol Res 1993, 285:239-240.
90. Brandner J.M. Pores in the epidermis: aquaporins and tight junctions. Int J Cosmet Sci 2007, 29:413-422.
91. Lundstrom A., Egelrud T. Cell shedding from human plantar skin in vitro: evidence of its dependence on endogenous proteolysis. J Invest Dermatol 1988, 91:340-343.
92. Blank I.H., Moloney J., Emslie A.G., Simon I., Apt C. The diffusion of water across the stratum corneum as a function of its water content. J Invest Dermatol 1984, 82:188-194.
93. Lodén M. Prevention or promotion of dryness and eczema by moisturizers?. Expert Rev Dermatol 2008, 3:667-676.
94. Lodén M. Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 1996, 288:103-107.
95. Hachem J.P., De Paepe K., Vanpée E., Kaufman L., Rogiers V., Roseeuw D. The effect of two of moisturisers on skin barrier damage in allergic contact dermatitis. Eur J Dermatol 2002, 12:136-138.
96. Duval D., Lindberg M., Boman A., Johansson S., Edlund F., Lodén M. Differences among moisturizers in affecting skin susceptibility to hexyl nicotinate, measured as time to increase skin blood flow. Skin Res Technol 2002, 8:1-5.
97. Buraczewska I., Lodén M. Treatment of surfactant-damaged skin in humans with creams of different pH. Pharmacology 2005, 73:1-7.
98. Levin J., Maibach H. Human skin buffering capacity: an overview. Skin Res Technol 2008, 14:121-126.
99. Lodén M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997, 36:256-260.
100. Lodén M., Bárány E., Mandahl P., Wessman C. The influence of urea treatment on skin susceptibility to surfactant-induced irritation: a placebo-controlled and randomized study. Exog Dermatol 2004, 3:1-6.
101. Lodén M., Wessman C. The influence of a cream containing 20% glycerin and its vehicle on skin barrier properties. Int J Cosmet Sci 2001, 23:115-120.
102. Lindberg M., Forslind B. The skin as a barrier. Dry skin and moisturizers. Chemistry and function 2005, 9-21. CRC Press Taylor & Francis Group, Boca Raton. M. Loden, H.I. Maibach (Eds.).
103. Bouwstra J.A., Gooris G.S., Dubbelaar F.E., Weerheim A.M., Ponec M. pH, cholesterol sulfate, and fatty acids affect the stratum corneum lipid organization. J Investig Dermatol Symp Proc 1998, 3:69-74.
104. Pilgram G.S., van der Meulen J., Gooris G.S., Koerten H.K., Bouwstra J.A. The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim Biophys Acta 2001, 1511:244-254.
105. Tsang M., Guy R.H. Effect of Aqueous Cream BP on human stratum corneum in vivo. Br J Dermatol 2010, 163:954-958.
106. Buraczewska I., Berne B., Lindberg M., Loden M., Torma H. Long-term treatment with moisturizers affects the mRNA levels of genes involved in keratinocyte differentiation and desquamation. Arch Dermatol Res 2009, 301:175-181.
107. Weinberg W.C., Denning M.F. P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 2002, 13:453-464.
108. Chang B.D., Watanabe K., Broude E.V., et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A 2000, 97:4291-4296.
109. Buraczewska I., Berne B., Lindberg M., Loden M., Torma H. Moisturizers change the mRNA expression of enzymes synthesizing skin barrier lipids. Arch Dermatol Res 2009, 301:587-594.
110. Ekholm I.E., Brattsand M., Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J Invest Dermatol 2000, 114:56-63.
111. Ekholm E., Egelrud T. Expression of stratum corneum chymotryptic enzyme in relation to other markers of epidermal differentiation in a skin explant model. Exp Dermatol 2000, 9:65-70.
112. Fluhr J.W., Gloor M., Lehmann L., Lazzerini S., Distante F., Berardesca E. Glycerol accelerates recovery of barrier function in vivo. Acta Derm Venereol 1999, 79:418-421.
113. Held E., Lund H., Agner T. Effect of different moisturizers on SLS-irritated human skin. Contact Dermatitis 2001, 44:229-234.
114. Kucharekova M., Schalkwijk J., Van de Kerkhof P.C.M., Van de Valk P.G. Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction. Contact Dermatitis 2002, 46:331-338.
115. Mortz C.G., Andersen K.E., Halkier-Sørensen L. The efficacy of different moisturizers on barrier recovery in hairless mice evaluated by non-invasive bioengineering methods. A model to select the potentially most effective product. Contact Dermatitis 1997, 36:297-310.
116. Zettersten E.M., Ghadially R., Feingold K.R., Crumrine D., Elias P.M. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol 1997, 37:403-408.
117. Ghadially R., Halkier_Sorensen L., Elias P.M. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 1992, 26:387-396.
118. Lodén M., Barany E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm Venereol 2000, 80:412-415.
119. Chamlin S.L., Kao J., Frieden I.J., et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002, 47:198-208.
120. Man M.M., Feingold K.R., Thornfeldt C.R., Elias P.M. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 1996, 106:1096-1101.
121. De Paepe K., Derde M.P., Reseeuw D., Rogiers V. Incorporation of ceramide 3B in dermatocosmetic emulsions: effect of the transepidermal water loss of sodium lauryl sulphate-damaged skin. JAEDV 2000, 14:272-279.
122. Barany E., Lindberg M., Lodén M. Unexpected skin barrier influence from nonionic emulsifiers. Int J Pharm 2000, 195:189-195.
123. Proksch E., Nissen H.P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. J Dermatol Treat 2002, 13:173-178.
124. Tanno O., Ota Y., Kitamura N., Katsube T., Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 2000, 143:524-531.
125. Summers R.S., Summers B., Chandar P., Feinberg C., Gursky R., Rawlings A.V. The effect of lipids, with and without humectant, on skin xerosis. J Soc Cosmet Chem 1996, 47:27-39.
126. Draelos Z.D. Moisturizing cream ameliorates dryness and desquamation in participants not receiving topical psoriasis treatment. Cutis 2008, 82:211-216.
127. Halkier-Sorensen L., Thestrup-Pedersen K. The efficacy of a moisturizer (Locobase) among cleaners and kitchen assistants during everyday exposure to water and detergents. Contact Dermatitis 1993, 29:266-271.
128. Lodén M., Andersson A.C., Andersson C., Frodin T., Oman H., Lindberg M. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol 2001, 7:209-213.
129. Kikuchi K., Tagami H. Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons. Br J Dermatol 2008, 158:969-978.
130. Andersson A.-C., Lindberg M., Lodén M. The effect of two urea-containing creams on dry, eczematous skin in atopic patients. I. Expert, patient and instrumental evaluation. J Dermatol Treat 1999, 10:165-169.
131. Lodén M., Andersson A.-C., Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999, 140:264-267.
132. Sasaki Y., Tadaki T., Tagami H. The effects of a topical application of urea cream on the function of pathological stratum corneum. Acta Dermatol Kyoto 1989, 84:581.
133. Berardesca E., Vignoli G.P., Distante F., Rona C. Effects of glycolic acid on psoriasis. Clin Exp Dermatol 1998, 23:189.
134. Rawlings A.V., Davies A., Carlomusto M., et al. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res 1996, 288:383-390.
135. Berardesca E., Distante F., Vignoli G.P., Oresajo C., Green B. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol 1997, 137:934-938.
136. Gånemo A., Virtanen M., Vahlquist A. Improved topical treatment of lamellar ichthyosis: a double blind study of four different cream formulations. Br J Dermatol 1999, 141:1027-1032.
137. Kolbe L., Kligman A.M., Stoudemayer T. Objective bioengineering methods to assess the effects of moisturizers on xerotic leg of elderly people. J Dermatol Treat 2000, 11:241-245.
138. Lucky A.W., Leach A.D., Laskarzewski P., Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997, 14:321-324.
139. Giordano-Labadie F., Cambazard F., Guillet G., Combemale P., Mengeaud V. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis. J Dermatol Treat 2006, 17:78-81.
140. Draelos Z.D. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis 2008, 81:87-91.
141. Elias P.M., Hatano Y., Williams M.L. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008, 121:1337-1343.
142. Szczepanowska J, Reich A, Szepietowski JC Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol 2008, 19:614-618.
143. Wirén K., Nohlgård C., Nyberg F., et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009, 23:1267-1272.
144. Loden M., Wiren K., Smerud K., et al. Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study. Acta Derm Venereol 2010, 90:602-606.
145. Gollnick H., Kaufmann R., Stough D., et al. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Br J Dermatol 2008, 158:1083-1093.
146. Meurer M., Folster-Holst R., Wozel G., Weidinger G., Junger M., Brautigam M. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology 2002, 205:271-277.
147. Wollenberg A., Reitamo S., Girolomoni G., et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008, 63:742-750.
148. Meurer M., Fartasch M., Albrecht G., et al. Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology 2004, 208:365-372.
149. Berth-Jones J., Damstra R.J., Golsch S., et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003, 326:1367.
150. van den Oord R.A., Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009, 339:b2433.